SEC Filings |
|
 |
||||||||
|---|---|---|---|---|---|---|---|---|
| 4 | lerner, richard a | May 18, 2012 | 23.8 KB |
|
||||
| 4 | frost, phillip md et al | May 18, 2012 | 31.1 KB |
|
||||
| 4 | lerner, richard a | May 17, 2012 | 25.6 KB |
|
||||
| 4 | frost, phillip md et al | May 17, 2012 | 29.8 KB |
|
||||
| 4 | frost, phillip md et al | May 16, 2012 | 33.3 KB |
|
||||
| 4 | frost, phillip md et al | May 15, 2012 | 30.7 KB |
|
||||
| 4 | frost, phillip md et al | May 14, 2012 | 30.7 KB |
|
||||
| 4 | frost, phillip md et al | May 11, 2012 | 29.4 KB |
|
||||
| 10-Q | quarterly report | May 10, 2012 | 691.8 KB |
|
||||
| 4 | frost, phillip md et al | May 10, 2012 | 29.3 KB |
|
||||
| 4 | frost, phillip md et al | May 9, 2012 | 29.6 KB |
|
||||
| 4 | frost, phillip md et al | May 7, 2012 | 31.3 KB |
|
||||
| 4 | frost, phillip md et al | May 3, 2012 | 29.7 KB |
|
||||
| 4 | frost, phillip md et al | May 2, 2012 | 29.3 KB |
|
||||
| 4 | frost, phillip md et al | May 1, 2012 | 30.7 KB |
|
||||
| 4/A | frost phillip md et al | April 30, 2012 | 30.3 KB |
|
||||
| 4 | frost, phillip md et al | April 30, 2012 | 33.7 KB |
|
||||
| 4 | frost, phillip md et al | April 27, 2012 | 33.7 KB |
|
||||
| DEF 14A | definitive proxy statement | April 27, 2012 | 484.5 KB |
|
||||
| 424B3 | prospectus filed pursuant to rule 424 | April 26, 2012 | 114.9 KB |
|
||||
|
||||||||
Latest News
OPKO Health Receives Important U.S. Patent Allowance Read more
OPKO Health Enters into License Agreement with International Health Technology for Next Generation Prostate Cancer Biomarker Panel Read more
OPKO Health Receives Important U.S. Patent Allowance Read more
OPKO Health Announces the Start of Phase 3 Clinical Trials of Rolapitant for the Prevention of CINV Read more
More News